Skip to content
2000
Volume 20, Issue 9
  • ISSN: 1573-4129
  • E-ISSN: 1875-676X

Abstract

Aims

The aim of this study is to develop a sensitive, specific, rapid, and precise reverse-phase high-performance liquid chromatography (RP-HPLC) method and validate it to determine the Roflumilast in rat plasma.

Background

This study was aimed at developing a simple HPLC method for the detection of Roflumilast in rat plasma after ingestion of nanoparticles into the rat. A bioanalytical method was developed and validated.

Methodology

The drug sample (Roflumilast) was eluted isocratically using a mobile phase of Ammonium acetate buffer (pH = 7.0), acetonitrile, and methanol (20:40:40, v/v/v) made up the mobile phase on a Phenomenex C-18 (150mm x 4.68mm) pore size 5-micron analytical column. The drug was quantitatively determined at a UV wavelength of 254 nm using a standard calibration curve spanning the range of 1.5, 3.0, 4.5, 6.0, 7.5 μg/mL-1.

Results

The results showed that the limits of quantitation (LOQ) and detection (LOD) were 0.18 μg/ml and 0.54μg/ml, respectively. For both the intra-day and inter-day analysis, relative standard deviation (% RSD) was less than 2%, and the drug’s percentage accuracy was between 96% and 98%.

Conclusion

As per the established protocols, the developed method was quantitatively assessed for its intended use in terms of specificity, linearity, accuracy, precision, robustness, and sensitivity analysis. Roflumilast-loaded nanoparticles were effectively used to determine the drug entrapment efficiency using the currently validated RP-HPLC method. Besides, highly efficient drug extraction from plasma was attained, and mobile phase composition was suitable to the pharmacokinetic study of Roflumilast-loaded nanoparticles in rats.

Loading

Article metrics loading...

/content/journals/cpa/10.2174/0115734129348436241209110149
2024-12-13
2025-04-24
Loading full text...

Full text loading...

References

  1. YuanL. DaiX. YangM. CaiQ. ShaoN. Potential treatment benefits and safety of roflumilast in COPD: A systematic review and meta-analysis.Int. J. Chron. Obstruct. Pulmon. Dis.2016111477148310.2147/COPD.S10637027418821
    [Google Scholar]
  2. ChapmanR.W. HouseA. JonesH. RichardJ. CellyC. PreluskyD. TingP. HunterJ.C. LamcaJ. PhillipsJ.E. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.Eur. J. Pharmacol.20075712-321522110.1016/j.ejphar.2007.05.07417610865
    [Google Scholar]
  3. ZengY. ShenM. SinghalA. SevinkG.J.A. CroneN. BoyleA.L. KrosA. Enhanced liposomal drug delivery via membrane fusion triggered by dimeric coiled-coil peptides.Small20231937230113310.1002/smll.20230113337199140
    [Google Scholar]
  4. MatosC.M. Liposomes: The brave old world.Int. J. Mol. Sci.2023245434310.3390/ijms2405434336901770
    [Google Scholar]
  5. JahanfarS. GahavamiM. Khosravi-DaraniK. JahadiM. MozafariM.R. Entrapment of rosemary extract by liposomes formulated by Mozafari method: Physicochemical characterization and optimization.Heliyon2021712e0863210.1016/j.heliyon.2021.e0863235005281
    [Google Scholar]
  6. BanalaV.T. Chapter 20 - Current status of FDA-approved marketed nano drug products: regulatory considerations.Multifunctional Nanocarriers. MehraN.K. Elsevier202250152110.1016/B978‑0‑323‑85041‑4.00004‑4
    [Google Scholar]
  7. EndharapuSP. DES. KatlaV.M. Formulation optimization and evaluation of evaluation of transdermal drug delivery system of felodipine.Int. J. Pharm. Res. Technol.2023132101114
    [Google Scholar]
  8. SarafS.A. MauryaP. PandeyP. SinghS. SonkarA. SinghS. Appraisal of Felodipine nanocrystals for solubility enhancement and pharmacodynamic parameters on cadmium chloride induced hypertension in rats.Curr. Drug Deliv.202219562563410.2174/156720181866621072910435134325637
    [Google Scholar]
  9. LabanA. MarkovicS. StankovM. DjurdjevicP. simultaneous determination of gestodene and ethinyl estradiol in contraceptive formulations by RP-HPLC.Anal. Lett.200437227328210.1081/AL‑120027792
    [Google Scholar]
  10. SantoroM.I.R.M. KassabN.M. HasegawaM. Kedor-HackmannÉ.R.M. Kedor-HackmannE.R. Determination of steroid hormones in oral contraceptives by high-performance liquid chromatography.Drug Dev. Ind. Pharm.200228674174710.1081/DDC‑12000386612149967
    [Google Scholar]
  11. DeosthaleeP. BarhateV.D. Rapid liquid chromatographic method for the determination of roflumilast in the presence of degradation products.Indian J. Pharm. Sci.201072340140410.4103/0250‑474X.7049621188058
    [Google Scholar]
  12. LiW. LiX. SuH. ZhaoS. LiY. HuJ. Facile synthesis of chondroitin sulfate-stabilized gold nanoparticles.Mater. Chem. Phys.2011125351852110.1016/j.matchemphys.2010.10.023
    [Google Scholar]
  13. GbianD.L. OmriA. Lipid-based drug delivery systems for diseases managements.Biomedicines2022109213710.3390/biomedicines1009213736140237
    [Google Scholar]
  14. Pushpa LathaE. SailajaB. Bioanalytical method development and validation by HPLC: A review.J. Appl. Pharm.2014119
    [Google Scholar]
  15. DharmalingamS.R. RamamurthyS. ChidambaramK. NadarajuS. A simple HPLC bioanalytical method for the determination of doxorubicin hydrochloride in rat plasma: Application to pharmacokinetic studies.Trop. J. Pharm. Res.201413340941510.4314/tjpr.v13i3.15
    [Google Scholar]
  16. PandyaR.H. RathodR. MaheswariD.G. Bioanalytical method development and validation for simultaneous determination of linagliptin and metformin drugs in human plasma by RP-HPLC method.Pharmacophore201452202218
    [Google Scholar]
  17. DalviA.V. UppuluriC.T. BommireddyE.P. RaviP.R. Design of experiments-based RP – HPLC bioanalytical method development for estimation of Rufinamide in rat plasma and brain and its application in pharmacokinetic study.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.20181102-1103748210.1016/j.jchromb.2018.10.01430380466
    [Google Scholar]
  18. EmaraL.H. TahaN.F. El-AshmawyA.A. RaslanH.M. MursiN.M. A rapid and sensitive bioanalytical hplc method for determining diclofenac sodium in human plasma for bioequivalence studies.J. Liq. Chromatogr. Relat. Technol.201235152203221610.1080/10826076.2011.629391
    [Google Scholar]
  19. MehmoodY. KhanI.U. ShahzadY. KhalidS.H. IrfanM. AsgharS. YousafA.M. HussainT. KhalidI. Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma.Pak. J. Pharm. Sci.201932Suppl 41835184231680080
    [Google Scholar]
  20. AhmedA.Y. HPLC method validation for the estimation of aspirin in bulk and tablet dosage form as per USP.Int. J. Res. Adve. Techno.201974S6973
    [Google Scholar]
  21. CuiL. PoonJ. PoonS.K. ChenH. GaoJ. KwanP. FanK. LingZ. An improved independent component analysis model for 3D chromatogram separation and its solution by multi-areas genetic algorithm.BMC Bioinformatics201415S12Suppl. 12S810.1186/1471‑2105‑15‑S12‑S825474487
    [Google Scholar]
  22. JoseJ. NettoG. Role of solid lipid nanoparticles as photoprotective agents in cosmetics.J. Cosmet. Dermatol.201918131532110.1111/jocd.1250429441672
    [Google Scholar]
  23. MacNeillR. StromeyerR. UrbanowiczB. AcharyaV. MoussallieM. LC-MS/MS quantification of parathyroid hormone fragment 1-34 in human plasma.Bioanalysis20135441542210.4155/bio.12.33423414375
    [Google Scholar]
/content/journals/cpa/10.2174/0115734129348436241209110149
Loading
/content/journals/cpa/10.2174/0115734129348436241209110149
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): determination; ICH guidelines; plasma; quantification; roflumilast; RP-HPLC
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test